Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies

Rosiglitazone is an effective insulin-sensitizer, however associated with bone loss mainly due to increased bone resorption and bone marrow adiposity. We investigated the effect of the co-administration of fish oil rich in omega-3 fatty acids (FAs) on rosiglitazone-induced bone loss in C57BL/6 mice...

Descripción completa

Detalles Bibliográficos
Autores principales: Cugno, Chiara, Kizhakayil, Dhanya, Calzone, Rita, Rahman, Shaikh Mizanoor, Halade, Ganesh V., Rahman, Md M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121944/
https://www.ncbi.nlm.nih.gov/pubmed/33990655
http://dx.doi.org/10.1038/s41598-021-89827-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8121944/
https://www.ncbi.nlm.nih.gov/pubmed/33990655
http://dx.doi.org/10.1038/s41598-021-89827-8

Ejemplares similares